PPARγ: A critical determinant of body fat distribution in humans and mice

Yau-Sheng Tsai, Nobuyo Maeda

Research output: Contribution to journalReview article

37 Citations (Scopus)

Abstract

Evidence emerging from studies of humans and mice has indicated peroxisome proliferator-activated receptor γ (PPARγ) to be not only a key factor for adipogenesis but also a critical determinant of body fat distribution. Whereas genetically reduced PPARγ activity in adipose tissue leads to reduction of total fat mass in humans and in mice, mutations in the ligand-binding domain of PPARγ cause abnormal body fat distributions. It is less clear from mutation analysis how PPARγ is involved in metabolic disturbances such as insulin resistance and its cardiovascular complications. Nevertheless, similarities and differences in the phenotypes associated with PPARγ mutations in humans and in mouse models provide opportunities to dissect relationships between body fat distribution and its metabolic complications.

Original languageEnglish
Pages (from-to)81-85
Number of pages5
JournalTrends in Cardiovascular Medicine
Volume15
Issue number3
DOIs
Publication statusPublished - 2005 Jan 1

Fingerprint

Body Fat Distribution
Peroxisome Proliferator-Activated Receptors
Mutation
Adipogenesis
Insulin Resistance
Adipose Tissue
Fats
Ligands
Phenotype

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

@article{b5dce14ccd274b409dc1cf87d8bb8c5c,
title = "PPARγ: A critical determinant of body fat distribution in humans and mice",
abstract = "Evidence emerging from studies of humans and mice has indicated peroxisome proliferator-activated receptor γ (PPARγ) to be not only a key factor for adipogenesis but also a critical determinant of body fat distribution. Whereas genetically reduced PPARγ activity in adipose tissue leads to reduction of total fat mass in humans and in mice, mutations in the ligand-binding domain of PPARγ cause abnormal body fat distributions. It is less clear from mutation analysis how PPARγ is involved in metabolic disturbances such as insulin resistance and its cardiovascular complications. Nevertheless, similarities and differences in the phenotypes associated with PPARγ mutations in humans and in mouse models provide opportunities to dissect relationships between body fat distribution and its metabolic complications.",
author = "Yau-Sheng Tsai and Nobuyo Maeda",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.tcm.2005.04.002",
language = "English",
volume = "15",
pages = "81--85",
journal = "Trends in Cardiovascular Medicine",
issn = "1050-1738",
publisher = "Elsevier Inc.",
number = "3",

}

PPARγ : A critical determinant of body fat distribution in humans and mice. / Tsai, Yau-Sheng; Maeda, Nobuyo.

In: Trends in Cardiovascular Medicine, Vol. 15, No. 3, 01.01.2005, p. 81-85.

Research output: Contribution to journalReview article

TY - JOUR

T1 - PPARγ

T2 - A critical determinant of body fat distribution in humans and mice

AU - Tsai, Yau-Sheng

AU - Maeda, Nobuyo

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Evidence emerging from studies of humans and mice has indicated peroxisome proliferator-activated receptor γ (PPARγ) to be not only a key factor for adipogenesis but also a critical determinant of body fat distribution. Whereas genetically reduced PPARγ activity in adipose tissue leads to reduction of total fat mass in humans and in mice, mutations in the ligand-binding domain of PPARγ cause abnormal body fat distributions. It is less clear from mutation analysis how PPARγ is involved in metabolic disturbances such as insulin resistance and its cardiovascular complications. Nevertheless, similarities and differences in the phenotypes associated with PPARγ mutations in humans and in mouse models provide opportunities to dissect relationships between body fat distribution and its metabolic complications.

AB - Evidence emerging from studies of humans and mice has indicated peroxisome proliferator-activated receptor γ (PPARγ) to be not only a key factor for adipogenesis but also a critical determinant of body fat distribution. Whereas genetically reduced PPARγ activity in adipose tissue leads to reduction of total fat mass in humans and in mice, mutations in the ligand-binding domain of PPARγ cause abnormal body fat distributions. It is less clear from mutation analysis how PPARγ is involved in metabolic disturbances such as insulin resistance and its cardiovascular complications. Nevertheless, similarities and differences in the phenotypes associated with PPARγ mutations in humans and in mouse models provide opportunities to dissect relationships between body fat distribution and its metabolic complications.

UR - http://www.scopus.com/inward/record.url?scp=22544450826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22544450826&partnerID=8YFLogxK

U2 - 10.1016/j.tcm.2005.04.002

DO - 10.1016/j.tcm.2005.04.002

M3 - Review article

C2 - 16039966

AN - SCOPUS:22544450826

VL - 15

SP - 81

EP - 85

JO - Trends in Cardiovascular Medicine

JF - Trends in Cardiovascular Medicine

SN - 1050-1738

IS - 3

ER -